Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Acute Treatment

NCT03924193 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
141
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Yale University

Collaborators